Autoimmune antiphospholipid antibodies impairthe inhibition of activated factor X by protein Z/protein Z-dependent protease inhibitor

Journal of Thrombosis and Haemostasis

Volumn 1, Issue 8, 2003, Pages 1764-1770

  Forastiero, R R ^a   Martinuzzo, M E ^a   Lu, L ^b   Broze, G J ^b  

^a HOSPITAL UNIVERSITARIO FUNDACIÓN FAVALORO   (Argentina)

^b BARNES JEWISH HOSPITAL   (United States)

Author keywords

Antiphospholipid syndrome; Protein Z; Protein Z dependent protease inhibitor; Thrombosis.

Indexed keywords

BETA2 GLYCOPROTEIN 1; BLOOD CLOTTING FACTOR 10A; GLYCOPROTEIN; IMMUNOGLOBULIN G; PHOSPHOLIPID ANTIBODY; PLASMA PROTEIN; PLASMA PROTEIN Z; SERINE PROTEINASE INHIBITOR; SERPINA10 PROTEIN, HUMAN;

ADOLESCENT; ADULT; AGED; ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD; CASE CONTROL STUDY; CHILD; DRUG ANTAGONISM; FEMALE; HUMAN; IMMUNOASSAY; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; PRESCHOOL CHILD; RISK; TIME;

ADOLESCENT; ADULT; AGED; ANTIBODIES, ANTIPHOSPHOLIPID; ANTIPHOSPHOLIPID SYNDROME; BETA 2-GLYCOPROTEIN I; BLOOD PROTEINS; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; FACTOR XA; FEMALE; GLYCOPROTEINS; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; RISK; SERPINS; TIME FACTORS;

EID: 2142773072     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1046/j.1538-7836.2003.00303.x     Document Type: Article

References (30)

1. Broze GJ Jr. Protein Z-dependent regulation of coagulation. Thromb Haemost 2001; 86: 8-13.
2. Kemkes-Matthes B, Matthes KJ. Protein Z. Semin Thromb Hemost 2001; 27: 551-6.
3. Han X, Fiehler R, Broze GJ Jr. Isolation of a protein Z-dependent plasma protease inhibitor. Proc Natl Acad Sci USA 1998; 95: 9250-5.
4. Han X, Fiehler R, Broze GJ Jr. Characterization of the protein Z-dependent protease inhibitor. Blood 2000; 96: 3049-55.
5. Tabatabai A, Fiehler R, Broze GJ Jr. Protein Z circulates in plasma in a complex with protein Z-dependent protease inhibitor. Thromb Haemost 2001; 85: 655-60.
6. Yin ZF, Huang ZF, Cui J, Fiehler R, Lasky N, Ginsburg D, Broze GJ Jr. Prothrombotic phenotype of protein Z deficiency. Proc Natl Acad Sci USA 2000; 97: 6734-8.
7. Kemkes-Matthes B, Nees M, Kiihnel G, Matzdorff A, Matthes KJ. Protein Z influences the prothrombotic phenotype in factor V Leiden patients. Thromb Res 2002; 106: 183-5.
8. Vasse M, Guegan-Massardier E, Borg JY, Woimant F, Soria C. Frequency of protein Z deficiency in patients with ischaemic stroke. Lancet 2001; 357: 933-4.
9. Heeb MJ, Paganini-Hill A, Griffin JH, Fisher M. Low protein Z levels and risk of ischemic stroke: differences by diabetic status and gender. Blood Cells Mol Dis 2002; 29: 139-44.
10. Gris JC, Quéré I, Dechaud H, Mercier E, Pincon C, Hoffet M, Vasse M, Mares P. High frequency of protein Z deficiency in patients with unexplained early fetal loss. Blood 2002; 99: 2606-8.
11. Paidas MJ, Ku DHW, Arkel YS, Reharber A, Lee MJ, Roshan D, Mulholland J, Shah M, O'Neil L, Davidson B, Ku V, Thurston A, Lockwood CJ. First trimester maternal protein Z levels are lower in patients with complicated pregnancies and patients with thrombophilia and subsequent adverse pregnancy outcomes. 44th Meeting of the American Society of Hematology, 2002, Philadelphia, PA, USA. Blood 2002; 100 (Suppl.): abstract 1021.
12. Kobelt K, Demarmels Biasiutti FD, Mattle HP, Lämmle B, Wuillemin WA. Protein Z in ischaemic stroke. Br J Haematol 2001; 114: 169-73.
13. Lopaciuk S, Bykowska K, Kwiecinski H, Czlonkowska A, Kuczynska-Zardzewialy A. Protein Z in young survivors of ischemic stroke. Thromb Haemost 2002; 88: 536.
14. Miletich JP, Broze GJ Jr. Human plasma protein Z antigen: range in normal subjects and effect of warfarin therapy. Blood 1987; 69: 1580-6.
15. McDonald JF, Shah AM, Schwalbe RA, Kisiel W, Dahlbäck B, Nelsestuen GL. Comparison of naturally occurring vitamin K-depen-dent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site. Biochemistry 1997; 36: 5120-7.
16. Wilson W, Gharavi A, Koike T, Lockshin M, Branch W, Piette J, Brey R, Derksen R, Harris E, Hughes G, Triplett D, Khamashta M. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an International Workshop. Arthritis Rheum 1999; 42: 1309-11.
17. Carreras LO, Forastiero RR, Martinuzzo ME. Which are the best biological markers of the antiphospholipid syndrome? J Autoimmun 2000; 15: 163-72.
18. Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002; 346: 752-63.
19. Carreras LO, Forastiero RR. Pathogenic role of antiprotein-phospholi-pid antibodies. Haemostasis 1996; 26: 340-57.
20. Dobado-Berrios P, López-Pedrera C, Velasco F, Cuadrado MJ. The role of tissue factor in the antiphospholipid syndrome. Arthritis Rheum 2001; 44: 2467-76.
21. Forastiero RR, Martinuzzo ME, Broze GJ. High titres of autoantibodies to tissue factor pathway inhibitor are associated with the antiphospholipid syndrome. J Thromb Raemost 2003; 1: 718-24.
22. 2-glycoprotein I associated with antiphospholipid syndrome suppress the inhibitory activity of tissue factor pathway inhibitor. Thromb Haemost 2000; 84: 653-6.
23. 2-glycoprotein I is necessary to inhibit protein C activity by monoclonal antibodies. Arthritis Rheum 1999; 42: 167-74.
24. Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulant: an update. Thromb Haemost 1995; 74: 1185-90.
25. 2-glycoprotein I and anti prothrombin antibodies to thrombosis and pregnancy loss in patients with antiphospholipid antibodies. Thromb Haemost 1997; 78: 1008-14.
26. Mann KG, Butenas S, Brummel K. The dynamics of thrombin formation. Arterioscler Thromb Vase Biol 2003; 23: 17-25.
27. Arnout J, Wittevrongel C, Vanrusselt M, Hoylaerts M, Vermylen J. Beta-2-glycoprotein I dependent lupus anticoagulants form stable bivalent antibody beta-2-glycoprotein I complexes on phospholipid surfaces. Thromb Haemost 1998; 79: 79-86.
28. 2-glycoprotein I complexes to lipid membranes. Biochemistry 1996; 35: 13833-42.
29. McColl MD, Maclean P, Tait C, Greer IA, Walker ID. Plasma protein Z deficiency is common in women with antiphospholipid antibodies. 44th Meeting of the American Society of Hematology, 2002, Philadelphia, PA, USA. Blood 2002; 100 (Suppl.): abstract 1046.
30. Steffano B, Forastiero R, Martinuzzo M, Kordich L. Low plasma protein Z levels in patients with antiphospholipid antibodies. Blood Coagul Fibrinolysis 2001; 12: 411-2.